EPIX · Categories · Form 4

EPIX - SEC Form 4 insider transactions

ESSA Pharma Inc. (EPIX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EPIX

• 236d
  President and CEO Parkinson David Ross returned 65,675 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Chief Financial Officer Wood David S. returned 33,343 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Director Berger Franklin M returned 784,404 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Director Glickman Richard M returned 43,240 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Director Requadt Scott returned 30,002 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Director Martin John Alexander returned 14,299 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 236d
  Director Thorell Marella returned 2,881 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 237d
  SEC Form 4 filed by Large owner Bvf Partners L P/Il

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 305d
  Large owner Bvf Partners L P/Il exercised 2,920,000 in-the-money shares at a strike of $0.00 and sold $293 worth of shares (156 units at $1.88) (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 580d
  Large owner Biotech Growth N V sold $12,018,409 worth of shares (7,879,583 units at $1.53), closing all direct ownership in the company (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 609d
  Chief Operating Officer Virsik Peter sold $4,185 worth of shares (694 units at $6.03), decreasing direct ownership by 8% to 7,776 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 637d
  Chief Operating Officer Virsik Peter sold $4,164 worth of shares (694 units at $6.00), decreasing direct ownership by 8% to 8,470 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 643d
  Chief Operating Officer Virsik Peter sold $12,554 worth of shares (2,082 units at $6.03), decreasing direct ownership by 19% to 9,164 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 763d
  Virsik Peter sold $4,823 worth of shares (694 units at $6.95), decreasing direct ownership by 6% to 11,246 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 774d
  Glickman Richard M exercised 3,750 shares at a strike of $4.90, increasing direct ownership by 9% to 43,240 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 794d
  Virsik Peter sold $5,510 worth of shares (694 units at $7.94), decreasing direct ownership by 5% to 11,940 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Zweifach Sanford S

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Thorell Marella

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Sollis Gary

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Requadt Scott

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Merendino Lauren

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Martin John Alexander

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Kantoff Philip W.

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Glickman Richard M

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Berger Franklin M

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Wood David S.

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Virsik Peter

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Parkinson David Ross

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 802d
  SEC Form 4 filed by Cesano Alessandra

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 825d
  Virsik Peter sold $6,232 worth of shares (694 units at $8.98), decreasing direct ownership by 5% to 12,634 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 852d
  Virsik Peter exercised 72,782 shares at a strike of $3.23 and sold $748,927 worth of shares (72,782 units at $10.29) (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 853d
  Virsik Peter sold $11,440 worth of shares (1,194 units at $9.58) and exercised 500 shares at a strike of $3.23, decreasing direct ownership by 5% to 13,328 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 873d
  Virsik Peter exercised 1,718 shares at a strike of $3.23 and sold $17,197 worth of shares (1,718 units at $10.01) (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 874d
  Requadt Scott disposed of 30,002 shares, decreasing direct ownership by 50% to 30,002 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 882d
  Virsik Peter sold $4,271 worth of shares (699 units at $6.11), decreasing direct ownership by 5% to 14,022 units (SEC Form 4)

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 927d
  SEC Form 4 filed by Wood David S.

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1250d
  SEC Form 4: Parkinson David Ross bought $59,041 worth of shares (24,434 units at $2.42), increasing direct ownership by 76% to 56,542 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1250d
  SEC Form 4: Berger Franklin M sold $729,052 worth of shares (272,840 units at $2.67), decreasing direct ownership by 29% to 684,404 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1250d
  SEC Form 4: Wood David S. bought $21,585 worth of shares (8,302 units at $2.60), increasing direct ownership by 33% to 33,343 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Zweifach Sanford S

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Wood David S.

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Virsik Peter

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Thorell Marella

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Sollis Gary

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Requadt Scott

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Parkinson David Ross

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Martin John Alexander

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Glickman Richard M

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Cesano Alessandra

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1315d
  SEC Form 4 filed by Berger Franklin M

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1319d
  SEC Form 4: Biotech Growth N V bought $8,219,600 worth of shares (2,000,000 units at $4.11), increasing direct ownership by 34% to 7,879,583 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1419d
  SEC Form 4: Biotech Growth N V bought $946,740 worth of shares (300,000 units at $3.16), increasing direct ownership by 5% to 5,879,583 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1421d
  SEC Form 4: Biotech Growth N V bought $1,726,226 worth of shares (588,869 units at $2.93), increasing direct ownership by 12% to 5,579,583 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1434d
  SEC Form 4: Parkinson David Ross bought $14,456 worth of shares (4,887 units at $2.96), increasing direct ownership by 18% to 32,108 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1502d
  SEC Form 4: Biotech Growth N V sold $146,925 worth of shares (25,100 units at $5.85), decreasing direct ownership by 0.50% to 4,990,714 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1753d
  SEC Form 4: BIOTECH GROWTH N V bought $2,218,800 worth of Common Shares (250,000 units at $8.88), increasing direct ownership by 5% to 5,015,814 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1922d
  SEC Form 4: M Franklin Berger bought $1,539,000 worth of Common Shares (57,000 units at $27.00), increasing ownership by 6% to 957,244 units

  4 - ESSA Pharma Inc. (0001633932) (Issuer)
• 1959d
  SEC Form 4 filed by S Sanford Zweifach

  4/A - ESSA Pharma Inc. (0001633932) (Issuer)
• 1959d
  SEC Form 4 filed by Marella Thorell

  4/A - ESSA Pharma Inc. (0001633932) (Issuer)
• 1959d
  SEC Form 4 filed by Gary Sollis

  4/A - ESSA Pharma Inc. (0001633932) (Issuer)

Other EPIX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends